tiprankstipranks

Edward J Schutter Insider Profile

4 Followers
Edward J Schutter, Director at Knight Therapeutics, holds 1.54M shares in TerrAscend Corp (Ticker: TSE:TSND), holds 1.20K shares in Knight Therapeutics (Ticker: KHTRF).
tipranks
Edward J Schutter

Edward J Schutter
Knight Therapeutics (KHTRF)
Director

Ranked #87,300 out of 100,336 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-36.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$842K
99.62%
0.38%
A breakdown of Edward J Schutter's holdings

Insider Roles

TerrAscend Corp
(TSND)
Director
Knight Therapeutics
(KHTRF)
Director
Roles that Edward J Schutter holds in companies

Most Profitable Insider Trade

Stock:
TerrAscend Corp
(TSND)
Rating:Informative Sell
Date:Jan 06, 2025 - Today
Return:+16.40%
The most profitable trade made by Edward J Schutter

Edward J Schutter's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Knight Therapeutics
Apr 07, 2015
Director
Uninformative Buy
9.99K
$4.64K
TerrAscend Corp
Jan 06, 2025
Director
Uninformative Sell
C$1.20M
List of latest transactions for each holding click on a transaction to see Edward J Schutter's performance on stock

Edward J Schutter insider profile FAQ

What is the percentage of profitable transactions made by Edward J Schutter?
The percentage of profitable transactions made by Edward J Schutter is 25%.
    What is the average return per transaction made by Edward J Schutter?
    The average return per transaction made by Edward J Schutter is -36.70%.
      What stocks does Edward J Schutter hold?
      Edward J Schutter holds: KHTRF, TSE:TSND stocks.
        What was Edward J Schutter’s latest transaction?
        Edward J Schutter latest transaction was an Uninformative Sell of ―.
          What was Edward J Schutter's most profitable transaction?
          Edward J Schutter’s most profitable transaction was an Informative Sell of TSE:TSND stock on January 6, 2025. The return on the trade was 16.40%.
            What is Edward J Schutter's role in Knight Therapeutics?
            Edward J Schutter's role in Knight Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.